Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: Agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells

被引:38
作者
Watt, Heather L. [2 ]
Kharmate, Geetanjali D. [1 ]
Kumar, Ujendra [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1W5, Canada
[2] McGill Univ, Royal Victoria Hosp, Dept Expt Med, Fac Med, Montreal, PQ H3A 1A1, Canada
关键词
Somatostatin; Somatostatin receptors; Epidermal growth factor; Epidermal growth factor receptors; Dimerization; Extracellular signal-regulated kinase; HORMONE-RELEASING HORMONE; ESTROGEN-RECEPTOR; PROGNOSTIC VALUE; ERBB RECEPTORS; MESSENGER-RNA; EGF RECEPTOR; SUBTYPE; FACTOR-I; EXPRESSION; PROTEIN;
D O I
10.1016/j.cellsig.2008.11.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of somatostatin (SST) and epidermal growth factor (EGF) in breast cancer is undisputed: however, the molecular mechanisms underlying their antiproliferative or proliferative effects are not well understood. We initially confirmed that breast turnout tissues express all five somatostatin receptors (SSTR1-5) and four epidermal growth factor receptors (ErbB1-4). Subsequently, to gain insight into the function of SSTRs and ErbBs in oestrogen receptor (ER)-positive (MCF-7) or ER alpha-negative (MDA-MB-231) breast cancer cells, we defined SSTR1, SSTR5 and ErbB1 mRNA and protein expression in these two tumour cell lines. Consistent with previous studies showing SSTR1/SSTR5 heterodimerization and having seen cell-specific and ligand-selective alterations in receptor expression, we next elucidated whether SSTR1 and SSTR5 functionally interactwith ErbB1 using pbFRET analysis. We subsequently determined the effects of SST and EGF either alone, or in combination, on selected downstream signalling molecules such as erk1/2, p38 and JNK. Here, we showed that both SST and EGF influenced erk1/2 phosphorylation and that SST modulated the effects of EGF in a cell-specific manner. We also demonstrated agonist-, time and cell-dependent regulation of p38 phosphorylation. We further investigated modulation of Grb2, SOS, Shc, SH-PTP1 and SH-PTP2. ErbB1 adaptor proteins known to play a role in MAPK activation, Shc, Grb2 and SOS, changed in an agonist- and cell-specific manner whereas, SH-PTP1 and SH-PTP2, adaptor proteins reported to interact with SSTRs, translocated from the cytosol to membrane in a cell-specific manner following SST and/or EGF treatment. Although several previous studies have shown crosstalk between RTKs and GPCRs, there are no reports describing SSTR (GPCR) modulation of ErbBs (RTK) in breast cancer. To the best of our knowledge, this is the first report describing crosstalk/interactions between SSTRs and ErbBs. (c) 2008 Published by Elsevier Inc.
引用
收藏
页码:428 / 439
页数:12
相关论文
共 78 条
[1]   Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma [J].
Abd El-Rehim, DM ;
Pinder, SE ;
Paish, CE ;
Bell, JA ;
Rampaul, RS ;
Blamey, RW ;
Robertson, JFR ;
Nicholson, RI ;
Ellis, IO .
BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1532-1542
[2]   Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination [J].
Alwan, HAJ ;
van Zoelen, EJJ ;
van Leeuwen, JEM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35781-35790
[3]   Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle [J].
Balsari, A ;
Casalini, P ;
Tagliabue, E ;
Greco, M ;
Pilotti, S ;
Agresti, R ;
Giovanazzi, R ;
Alasio, L ;
Rumio, C ;
Cascinelli, N ;
Colnaghi, MI ;
Ménard, S .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) :1543-1547
[4]   Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 - Co-immunoprecipitation and fluorescence resonance energy transfer analysis [J].
Baragli, Alessandra ;
Alturaihi, Haydar ;
Watt, Heather L. ;
Abdallah, Ali ;
Kumar, Ujendra .
CELLULAR SIGNALLING, 2007, 19 (11) :2304-2316
[5]   Molecular markers for predicting response to tamoxifen in breast cancer patients [J].
Ciocca, DR ;
Elledge, R .
ENDOCRINE, 2000, 13 (01) :1-10
[6]   Characterization of HER1 (c-erbB1) status in locally advanced breast cancer using fluorescence in situ hybridization and immunohistochemistry [J].
Corzo, C ;
Tusquets, I ;
Salido, M ;
Corominas, JM ;
Bellet, M ;
Suarez, M ;
Baró, T ;
Fabregat, X ;
Serrano, S ;
Solé, F .
TUMOR BIOLOGY, 2005, 26 (01) :25-30
[7]   Cellular biology of somatostatin receptors [J].
Csaba, Z ;
Dournaud, P .
NEUROPEPTIDES, 2001, 35 (01) :1-23
[8]   Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors [J].
Daub, H ;
Weiss, FU ;
Wallasch, C ;
Ullrich, A .
NATURE, 1996, 379 (6565) :557-560
[9]   Signal characteristics of G protein-transactivated EGF receptor [J].
Daub, H ;
Wallasch, C ;
Lankenau, A ;
Herrlich, A ;
Ullrich, A .
EMBO JOURNAL, 1997, 16 (23) :7032-7044
[10]  
deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.3.CO